Larvol Delta - Elevar-Therapeutics-Announces-Three-Abstracts-Accepted-for-Presentation-at-ESMO-Congress-2026

lirafugratinib (RLY-4008) - Elevar Therapeutics

AiTan (rivoceranib) - Elevar Therapeutics

AiRuiKa (camrelizumab) - Elevar Therapeutics

https://www.manilatimes.net/2026/07/28/tmt-newswire/globenewswire/elevar-therapeutics-announces-three-abstracts-accepted-for-presentation-at-esmo-congress-2026/2392459

Jul 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next